| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $8.34B | +0.9% |
| Cost of Revenue | $4.33B | -14.7% |
| Gross Profit | $4.02B | +25.8% |
| R&D Expense | $679.0M | +42.3% |
| SG&A Expense | $1.91B | -4.4% |
| Operating Income | $1.70B | +6.8% |
| Pre-tax Income | $917.0M | -16.6% |
| Income Tax | $168.0M | +10.7% |
| Net Income | $869.0M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $468.0M | -0.6% |
| Accounts Receivable | $1.93B | +7.2% |
| Inventory | $1.25B | -3.6% |
| Current Assets | $3.91B | +0.8% |
| Total Assets | $11.22B | -0.1% |
| Current Liabilities | $3.44B | -4.4% |
| Long-term Debt | $2.61B | +2.1% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.54B | +78.7% |
| Investing Cash Flow | -$216.0M | +78.0% |
| Financing Cash Flow | -$1.33B | -165.5% |
| -8.8% |
| EPS (Basic) | $7.69 | -7.6% |
| EPS (Diluted) | $7.67 | -7.4% |
| Stockholders' Equity |
| $3.65B |
| +4.5% |